Perspective Therapeutics CATX
NYSE CATX
$2.31 +0.01 (+0.55%)
As of: Oct 21, 2026 · 1:42 PM EDT

Perspective Therapeutics (CATX) Equity Income (2023 - 2026)

Updated

Perspective Therapeutics (CATX) recorded Equity Income of -$1,000 in Q2 2026.

Analysis

Perspective Therapeutics (CATX) Equity Income (2023 - 2026) Analysis & Trends

On a TTM basis, Perspective Therapeutics' Equity Income came in at -$2,000 as of Jun 30, 2026; for FY2025, it was -$2,000.

  • Across earlier years, Equity Income came in at -$8,000 in FY2024 and -$17,000 in FY2023.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Equity Income (Qtr)
1 Eli Lilly 1,133.99 Bn 1,102.58 Bn 19.71 Bn -
2 Johnson & Johnson 615.70 Bn 534.23 Bn 17.26 Bn -
3 AbbVie 501.05 Bn 474.16 Bn 12.70 Bn -
4 Merck 367.41 Bn 321.79 Bn 12.21 Bn -
5 Novartis Ag 297.75 Bn 261.74 Bn 11.24 Bn -2.00 Mn
6 Astrazeneca 261.20 Bn 234.88 Bn 12.86 Bn -10.00 Mn
7 Amgen 235.55 Bn 190.95 Bn 7.24 Bn -
8 Gilead Sciences 190.64 Bn 164.84 Bn 6.22 Bn -
9 Pfizer 169.29 Bn 115.93 Bn 10.94 Bn -
10 Perspective Therapeutics 279.31 Mn 42.41 Mn - -1,000.00
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 -1,000.00
Mar 31, 2025 -1,000.00
Dec 31, 2024 -2,000.00
Jun 30, 2024 -4,000.00
Mar 31, 2024 -2,000.00
Dec 31, 2023 -5,000.00
Sep 30, 2023 -12,000.00
API Access

Perspective Therapeutics Equity Income API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=equity-income&ticker=CATX&period=max&api_key=YOUR_API_KEY